期刊文献+

纳他霉素滴眼剂治疗真菌性角膜炎的疗效评估 被引量:13

Clinical effect analysis of natamycin eye drops to treat fungal keratitis
原文传递
导出
摘要 目的观察纳他霉素滴眼剂治疗真菌性角膜炎的临床效果,探讨真菌性角膜炎药物治疗的作用机制,以提高真菌性角膜炎患者临床疗效。方法选取2013年1月-2015年10月医院诊治的80例真菌性角膜炎患者资料,采用随机对照方法将患者分为对照组和试验组,每组40例,对照组采用伏立康唑滴眼液治疗,试验组采用纳他霉素滴眼剂局部滴眼治疗,比较两组疗效。结果试验组治疗总有效率为95%,显著高于对照组(P〈0.05);试验组治疗后复发率为5%,显著低于对照组(P〈0.05);两组患者治疗前视力≤0.1、0.1-0.3以及≥0.3者差异无统计学意义;试验组治疗后视力≥0.3,显著多于对照组(P〈0.05);试验组视力≤0.1、0.1-0.3者显著少于对照组(P〈0.05);两组患者治疗前眼部评分差异无统计学意义;试验组治疗后3d、7d、14d、28d眼部评分,显著低于对照组(P〈0.05)。结论真菌性角膜炎患者采用纳他霉素滴眼剂局部滴眼治疗效果理想,药物不良反应发生率低,能够改善患者视力,值得推广应用。 OBJECTIVE To observe the clinical effect of natamycin eye drops on fungal keratitis,and to discuss the mechanism of drug treatment so as to improve the clinical efficacy for patients with fungal keratitis.METHODS A total of 80cases(80eyes)of patients with fungal keratitis admitted from Jan.2013 to Oct.2015 were analyzed.Randomized controlled trials were conducted to divide them into control group and experiment group with 40 cases each.The control group received voriconazole eye drops,while the experimental group used natamycin of eye drops for topical treatment.The clinical effects of the two groups were compared.RESULTS The total effect rate of the experimental group was 95%,which was significantly higher than that of the control group(P〈0.05);the relapse rate of the experiment group was 5%,which was significantly lower than the control group(P〈0.05);the differences between two groups of patients with vision≤0.1,0.1-0.3and≥0.3were not significant;the cases of vision ≥0.3in experimental group after treatment were significantly more than the control group(P〈0.05);while visual acuity ≤0.1,0.1-0.3in experiment group were significantly less than the control group(P〈0.05);the differences of eye scores between two groups of patients before difference treatments were not significant;the eye scores of the experimental group after treatment in 3d,7d,14 d,28dwere significantly lower than those of the control group(P〈0.05).CONCLUSION Natamycin eye drops have great effect and low incidence of adverse drug reactions on patients with fungal keratitis.They can improve eye vision so can be applied widely.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第13期3055-3057,共3页 Chinese Journal of Nosocomiology
基金 湖北省教育厅中青年人才基金资助项目(Q20151901)
关键词 真菌性角膜炎 纳他霉素滴眼剂 治疗效果 药理 Fungal keratitis Natamycin eye drops Treatment effect Pharmacology
  • 相关文献

参考文献10

  • 1刘丽梅,史伟云,王婷,高华.2004至2011年感染性角膜炎行角膜移植手术的适应证及手术方式变化趋势的研究[J].临床眼科杂志,2013,21(1):1-4. 被引量:9
  • 2陈蔚.适宜中国国情的角膜移植技术的挑战和创新[J].中华眼视光学与视觉科学杂志,2012,14(8):449-452. 被引量:6
  • 3Tabibian D,Richoz O,Riat A,et al.Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis[J].J Refract Surg,2014,30(12):855-857. 被引量:1
  • 4满子惠,杨燕宁,邢怡桥,曹瑾,饶卓群.角膜溃疡清创联合抗真菌治疗真菌性角膜炎[J].临床误诊误治,2013,26(2):87-89. 被引量:23
  • 5Sharma N,Agarwal P,Sinha R,et al.Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis:case series[J].Br J Ophthalmol,2011,95(12):1735-1737. 被引量:1
  • 6Rogers GM,Goins KM,Sutphin JE,et al.Outcomes of treatment of fungal keratitis at the University of Iowa Hospitals and Clinics:a 10-year retrospective analysis[J].Cornea,2013,32(8):1131-1136. 被引量:1
  • 7Fazly Bazzaz BS,Khameneh B,Jalili-Behabadi MM,et al.Preparation,characterization and antimicrobial study of a hydrogel(soft contact lens)material impregnated with silver nanoparticles[J].Cont Lens Anterior Eye,2014,37(3):149-152. 被引量:1
  • 8Choi KS,Yoon SC,Rim TH,et al.Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis[J].J Ocul Pharmacol Ther,2014,30(5):381-386. 被引量:1
  • 9Mimouni M,Tam G,Paitan Y,et al.Safety and efficacy of intrastromal injection of 5%natamycin in experimental fusarium keratitis[J].J Ocul Pharmacol Ther,2014,30(7):543-547. 被引量:1
  • 10Taylan Sekeroglu H,Erdem E,Yagmur M,et al.Successful medical management of recalcitrant Fusarium solani keratitis:molecular identification and susceptibility patterns[J].Mycopathologia,2012,174(3):233-237. 被引量:1

二级参考文献32

  • 1Jun-Yi Wang, Li-Xin Xie, Xiu-Sheng Song,,Jing Zhao.Trends in the indications for penetrating keratoplasty in Shandong,2005-2010[J].International Journal of Ophthalmology(English edition),2011,4(5):492-497. 被引量:4
  • 2钟文贤,谢立信,史伟云,孙士营.真菌性角膜炎654例感染谱分析[J].中华医学杂志,2006,86(24):1681-1685. 被引量:65
  • 3Leading Group of the Second China National Sample Survey on Disability, National Bureau of Statistics of the People’s Republic of China.2006年第二次全国残疾人抽样调查主要数据公报[J].中国康复理论与实践,2006,12(12):1013-1013. 被引量:158
  • 4翟华蕾,谢立信.真菌性角膜炎的临床研究进展[J].中华医学杂志,2007,87(33):2372-2374. 被引量:15
  • 5Xie L, Qi F, Gao H, et al. Major shifts in corneal transplantation procedures in north China: 5316 eyes over 12 years. Br J Ophthalmol,2009,93 : 1291-1295. 被引量:1
  • 62010 Eye Banking Statistical Report Eye Bank Association of America 2011. http://www.restoresight.org(accessed Nov 28,2011). 被引量:1
  • 7Chen W, Lin Y, Zhang X, et al. Comparison of fresh corneal tissue versus glycerin-cryopreserved corneal tissue in deepanterior lamellar keratoplasty. Invest Ophthalmol Vis Sci, 2010,51:775-781. 被引量:1
  • 8Li JY, Shi S, Zhang X, et al. Comparison of different methods of glycerol preservation for deep anterior lamellar keratoplasty eligible corneas. Invest Ophthalmol Vis Sci,2012,in press. 被引量:1
  • 9Li J, Yu L, Deng Z, et al. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas. Am J Ophthalmol,2011,152: 762-770. 被引量:1
  • 10Xie L, Shi W, Liu Z, et al. Lamellar keratoplasty for the treatment of fungal keratitis. Cornea,2002,21:33-37. 被引量:1

共引文献33

同被引文献78

引证文献13

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部